Analysts expect over 2018 rising revenue Carl Zeiss Meditec

On Monday the German Carl Zeiss Meditec will publish its past quarters figures. Over the current book year the total revenue will be 1,41 billion euros (consensus estimates). This is rather significant more than 2017's revenue of 1,28 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2018

The analysts expect for 2018 a net profit of 158 million euros. The majority of the analysts expects for this year a profit per share of 1,77 euros. Based on this the price/earnings-ratio is 46,3.

Analysts expect a dividend of 0,62 cents per share. Thus the dividend yield equals 0,76 percent. The average dividend yield of the pharmaceutical companies equals a moderate 0,5 percent.

Most recent target prices around 74 euros

The latest 3 recommendations for the pharmaceutical company were provided by Independent Research, Nord Landesbank and Kepler Capital Markets.

Carl Zeiss Meditec's market capitalization is around 7,33 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last February the stock is even 69 percent higher. This year the stock price moved between 47 and 83 euro. Since 2008 the stock price is almost 793 percent higher.

At 10.52 the stock trades 1,4 percent lower at 81,95 euros.

Historical stock prices Carl Zeiss Meditec period 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.